I47.2 Ventricular tachycardia

Name of the Condition

• Ventricular Tachycardia
• ICD-10 Code: I47.2

Summary

Ventricular tachycardia (VT) is a rapid heart rhythm originating in the ventricles, characterized by three or more consecutive premature ventricular beats at a rate exceeding 100 beats per minute. It is a serious arrhythmia that can reduce cardiac output and may progress to life-threatening conditions. VT can occur in individuals with or without structural heart disease and may present as sustained or non-sustained episodes.

Causes

VT typically results from abnormalities in the heart’s electrical conduction system within the ventricles. Common causes include scar tissue from prior myocardial infarction, cardiomyopathy, myocarditis, or electrolyte imbalances. Other triggers include ischemia, drug toxicity (e.g., digoxin, antiarrhythmics), or congenital heart defects. In some cases, the cause may be idiopathic.

Risk Factors

• History of myocardial infarction or coronary artery disease
• Structural heart disease (e.g., cardiomyopathy, valvular disorders)
• Electrolyte abnormalities (e.g., hypokalemia, hypomagnesemia)
• Use of proarrhythmic medications or stimulants
• Genetic predisposition to arrhythmias
• Prior cardiac surgery or catheter ablation

Symptoms

• Rapid, regular heartbeat (palpitations)
• Dizziness or lightheadedness
• Shortness of breath
• Chest pain or pressure
• Syncope (fainting) in severe cases
• Fatigue or weakness during episodes

Diagnosis

Diagnosis involves evaluating symptoms, medical history, and electrocardiographic (ECG) findings. A 12-lead ECG during an episode confirms VT by demonstrating wide QRS complexes and atrioventricular dissociation. Additional tests, such as echocardiography, cardiac MRI, or electrophysiology studies, may assess structural or functional heart abnormalities. Holter monitoring or event recorders may capture intermittent episodes.

Treatment Options

Treatment depends on stability and underlying causes. Stable patients may receive antiarrhythmic medications (e.g., amiodarone, lidocaine) or electrical cardioversion. Unstable patients require immediate defibrillation. Long-term management may include catheter ablation, implantable cardioverter-defibrillator (ICD) placement, or addressing reversible causes (e.g., electrolyte correction, ischemia treatment).

Prognosis and Follow-Up

Prognosis varies based on underlying heart disease and episode duration. Sustained VT in patients with structural heart disease carries a higher risk of sudden cardiac death. Follow-up includes regular cardiac monitoring, medication adjustments, and ICD checks. Lifestyle modifications and management of comorbidities (e.g., heart failure) are critical for reducing recurrence.

Complications

• Sudden cardiac arrest or death
• Heart failure due to prolonged tachycardia
• Thromboembolic events from reduced cardiac output
• Recurrent arrhythmias requiring repeated interventions

Lifestyle & Prevention

• Avoid stimulants (e.g., caffeine, nicotine)
• Manage stress and anxiety
• Maintain electrolyte balance through diet or supplements
• Follow prescribed cardiac rehabilitation programs
• Adhere to medication regimens for underlying conditions

When to Seek Professional Help

Seek immediate medical attention for:

• Sudden, severe chest pain or palpitations
• Fainting (syncope) or near-fainting episodes
• Shortness of breath or dizziness lasting more than a few minutes
• Known VT with new or worsening symptoms

Tips for Medical Coders

Document the episode type (sustained/non-sustained), underlying causes (e.g., post-MI, cardiomyopathy), and treatment interventions (e.g., cardioversion, ablation). Include details on cardiac function (e.g., ejection fraction) and comorbidities to support code specificity. Ensure ECG or diagnostic test results are available to confirm ventricular origin and rule out supraventricular tachycardia with aberrancy.